CART-ddBCMA

Overview

CART-ddBCMA is a BCMA directed CAR T cell therapy in development for multiple myeloma.

SparkCures ID 363
Developed By Arcellx, Inc.
Generic Name CART-ddBCMA
Treatment Classifications
Treatment Targets

Clinical Trials

All Clinical Trials

View all active clinical trials around the US.

Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Smoldering Myeloma
Monoclonal Gammopathy of Undetermined Significance (MGUS)

Resources

There are no resources, links or videos to display for this treatment.